Hogan Lovells advises Sartorius Group on a GBP 3.5 million investment in SPARTA Biodiscovery Ltd.

Press releases | 23 October 2023

Led by Frankfurt partner Dr Christoph Naumann and Birmingham counsel Charles Jemmett, global law firm Hogan Lovells has advised the German Sartorius group on a tranched investment through its investment unit Sartorius Ventures of up to £3.5 million (around €4 million) in UK-based SPARTA Discovery Ltd.

SPARTA Discovery's analysis platform helps to speed up the development, manufacture, and quality control of nanoparticles for biopharmaceutical drugs. The SPARTA technology – Single Particle Automated Raman Trapping Analysis – uses spectroscopy to analyze populations of individual nanoparticles quickly and automatically at high throughput – helping to accelerate nanoparticle development and optimize quality control during production. Nanoparticles are small polymer or lipid capsules that act as carriers to deliver active agents to the target cells.

A team of Frankfurt, London and Birmingham-based lawyers provided legal advice to Sartorius group on all matters relating to the investment agreement.

Hogan Lovells team for Sartorius Group

Frankfurt

Dr Christoph Naumann (Partner, Mergers & Acquisitions);

London/Birmingham

Charles Jemmett (Counsel) and David Rizzuto (Associate) (both Mergers & Acquisitions);

Jane Summerfield (Partner) and Bea Watts (Associate) (both Regulatory/Life Sciences);

Fiona Bantock (Partner), Callum Fowers (Senior Associate) and Ellie Pardy (Associate) (all Tax);

Christopher Peacock (Counsel) and Alex Latham (both Competition);

Stefan Martin (Partner) and Eleanor Doubleday (Associate) (both Employment);

Jabeen Rizvi (Associate) (Privacy and Cyber Security).

Sartorius legal inhouse team

Jens Michael Artelt (Head of Legal Affairs & Compliance), Katrin Sebastian (Head of M&A & Corporate Compliance) and Heiner Wedeken (Specialist M&A & Corporate Compliance).